Retrospective evaluation of 3% NaCl treatment in patients with symptomatic hyponatremia in the emergency department

Basit Öğe Kaydı
dc.authoridözçete, enver/0000-0002-1685-2369
dc.authorwosidözçete, enver/GQQ-2198-2022
dc.contributor.authorÖzçete, Enver
dc.contributor.authorArslan, Bahadır
dc.date.accessioned2024-08-25T18:53:49Z
dc.date.available2024-08-25T18:53:49Z
dc.date.issued2023
dc.departmentEge Üniversitesien_US
dc.description.abstractAim: As the most common electrolyte disorder in the Emergency Department, hyponatremia is a serious medical condition associated with a high risk of morbidity and mortality. Hypertonic saline is an effective treatment for symptomatic hyponatremia. This study aims to determine the effective variables in serum sodium elevation and overcorrection with 3% NaCl treatment in patients with symptomatic hyponatremia in the emergency department.Material and Methods: In this study, we conducted a retrospective analysis of the efficacy of 3% NaCl treatment in symptomatic hyponatremic patients over 18 years of age. We described patients' characteristics and outcome variables.Results: In our study, 582 patient files were reviewed. In total, 270 patients were excluded from the study. Ultimately, 312 patients were included in our study. The mean baseline sNa in the patients was 116 +/- 4.5 mmol/L. The most common Hypertonic 3% NaCl treatment was Rapid Intermittent Bolus with a rate of 64.4%. A minimum of 5 mmol/l increase in serum Na was observed in 36.5% of patients following the first treatment. In any period, 20.5% of patients had a rise in sNa of more than 10 mmol/L within the first 24 h.Discussion: For treating symptomatic hyponatremia with 3% NaCl, a target serum Na of 125 mmol/L may be used along with a 5 mmol/L increase in serum Na. In the prevention of excessive serum Na elevation, 3% NaCl treatment in a volume smaller than baseline serum Na levels < 125 mmol/L may be considered.en_US
dc.identifier.doi10.4328/ACAM.21724
dc.identifier.endpage878en_US
dc.identifier.issn2667-663X
dc.identifier.issue10en_US
dc.identifier.startpage873en_US
dc.identifier.urihttps://doi.org/10.4328/ACAM.21724
dc.identifier.urihttps://hdl.handle.net/11454/103274
dc.identifier.volume14en_US
dc.identifier.wosWOS:001094073000003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherBayrakol Medical Publisheren_US
dc.relation.ispartofAnnals of Clinical and Analytical Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz20240825_Gen_US
dc.subjectHyponatremiaen_US
dc.subjectHypertonic Salineen_US
dc.subjectEmergency Departmenten_US
dc.subjectHypertonic Salineen_US
dc.subjectRapid Correctionen_US
dc.subjectRisk-Factorsen_US
dc.subjectSodiumen_US
dc.subjectOutcomesen_US
dc.titleRetrospective evaluation of 3% NaCl treatment in patients with symptomatic hyponatremia in the emergency departmenten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu